Approaching the control of viral hepatitis type B.
D000596:Amino Acids / Q000032:analysis; D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control; D002674:Child, Institutionalized; D000939:Epitopes; D006168:Guinea Pigs; D006281:Health Occupations; D006509:Hepatitis B / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000096:biosynthesis; D006511:Hepatitis B Antigens / Q000032:analysis*; D006515:Hepatitis B virus / Q000032:analysis / Q000276:immunology*; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D008113:Liver Neoplasms / Q000517:prevention & control; D008887:Military Medicine; D009784:Occupational Diseases / Q000517:prevention & control; D006435:Renal Dialysis / Q000009:adverse effects; D014611:Vaccination; D014765:Viral Vaccines
D000596:Amino Acids; D000939:Epitopes; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D014765:Viral Vaccines